Workflow
诺诚健华: 诺诚健华医药有限公司2025年股东周年大会决议公告
Zheng Quan Zhi Xing·2025-06-20 13:26

Meeting Overview - The shareholders' meeting was held on June 20, 2025, at Beijing Changping District [1] - A total of 222 ordinary shareholders attended, with 209 from A-shares and 13 from overseas listed foreign shares [1] - The total voting rights held by ordinary shareholders amounted to 717,515,946, with A-share shareholders holding 55,320,790 and overseas listed foreign shareholders holding 662,195,156 [1] Voting Results - All resolutions presented at the meeting were approved, with no rejected proposals [1][4] - The financial statements, board report, and auditor's report were approved with 99.9446% of ordinary shareholders voting in favor [4] - The resolution regarding the appointment of auditors was also passed with a significant majority [8] Shareholder Voting Breakdown - Ordinary shareholders voted 717,070,982 in favor of the financial statements, representing 99.9446% [4] - A-share shareholders voted 55,016,826 in favor, which is 99.5355% [4] - Overseas listed foreign shareholders showed overwhelming support with 99.9968% voting in favor [4] Legal Compliance - The meeting's procedures complied with the relevant laws and regulations, including the Company Law and the company's articles of association [3][9] - The voting process was conducted in accordance with the rules set forth by the Shanghai Stock Exchange and the applicable laws of the Cayman Islands [3][9] Auditor Appointment - The company reappointed Ernst & Young as its auditors and authorized the board to determine their remuneration [8]